Live News EQUITY L impact Jun 30, 2026, 05:08 PM UTC

Kymera Therapeutics shares are trading higher after B of A Securities raised its price target on the stock from $110 to $125.

Kymera Therapeutics shares are trading higher after B of A Securities raised its price target on the stock from $110 to $125.

SQUAWKNEWS Updated Jun 30, 2026, 05:08 PM UTC

Kymera Therapeutics shares are trading higher after B of A Securities raised its price target on the stock from $110 to $125.